Arvinas, Inc. (ARVN) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
About Arvinas, Inc.
Arvinas, Inc. is led by CEO Randy Teel, employs 430 people, headquartered in US, publicly traded since 2018.
Arvinas, Inc. (ARVN) stock trades at $7.30 with a market capitalization of $471.00M. The stock is valued at a price-to-earnings (P/E) ratio of 39.00, price-to-book of 0.85, price-to-sales of 1.51. Over the past 52 weeks the stock has ranged between $6.79 and $14.51, and currently trades 49.7% below its 52-week high.
On profitability, Arvinas, Inc. generates a return on equity (ROE) of 1.91%, return on capital employed of -2.38%, an operating margin of -43.73%, a net profit margin of 2.94%.
Arvinas, Inc. by the numbers, 2016–2025
Between 2016 and 2025 Arvinas, Inc. reported revenue of $7.0M rising to $263.0M, a change of +3657.1% across 10 years. Compounded, revenue has grown 58.9% a year over five years, 26.1% over three, 0.0% over the last twelve months. Net profit fell to $-81.0M.
Operating margin went from -246.9% in 2016 to -43.8% in 2025, a gain of 203.2 percentage points. The most recent net margin is 2.94%. On a trailing twelve-month basis to Jun '26, revenue is $318.0M and net profit $9.0M.
Borrowings stand at $9.0M, cash from operations was $-274.0M in the latest year, positive in 2 of the last 10.
Return on equity has averaged -36.8% over five years, and was -18.7% in the most recent year.
The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Arvinas, Inc. (ARVN) — frequently asked questions
What is Arvinas, Inc. (ARVN) stock price today?
Arvinas, Inc. (ARVN) is currently trading at $7.30, down 5.44% today.
What is ARVN P/E ratio?
Arvinas, Inc.'s P/E ratio is 39.00. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is ARVN return on equity (ROE)?
Arvinas, Inc.'s return on equity (ROE) is 1.91%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Arvinas, Inc.'s market cap?
Arvinas, Inc. has a market capitalization of $471.00M.
Does ARVN pay a dividend?
Arvinas, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does ARVN carry?
Arvinas, Inc. has a debt-to-equity ratio of 0.01. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is ARVN's profit margin?
Arvinas, Inc. reports a net profit margin of 2.94% — the share of revenue left after every cost, including tax and interest.
What sector is ARVN in?
Arvinas, Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is ARVN listed on?
Arvinas, Inc. trades on NASDAQ under the ticker ARVN.
What is ARVN's 52-week range?
Over the last year Arvinas, Inc. has traded between $6.79 and $14.51.
Related Healthcare Stocks
Popular Stocks
Screens ARVN currently matches
On the figures above, Arvinas, Inc. passes the filters for 9 of our ready-made screens, among them Day Losers Stocks, Small Cap Stocks, Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.